Skip to content

Interest coverage at other companies

Abbott logo
AbbottABT
14.4×+1.4×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
22.7×+17.6×
Danaher logo
DanaherDHR
18.6×+1.7×
Opko Health logo
Opko HealthOPK
-1×-0.4×
Agilent Technologies logo
Agilent TechnologiesA
14.8×+2.0×
Labcorp Holdings logo
Labcorp HoldingsLH
6.4×+1.4×

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-51.4%
Enterprise value$3.8B-20.1%
P/S0.3×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Based on trailing twelve months.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's interest coverage?
QuidelOrtho Corporation (QDEL) reported interest coverage of -5.2× in Q1 2026.
How has QuidelOrtho Corporation's interest coverage changed year-over-year?
QuidelOrtho Corporation's interest coverage decreased by 403.5% year-over-year, from -1× to -5.2×.
What is the long-term trend for QuidelOrtho Corporation's interest coverage?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's interest coverage has grown at a -22.6% compound annual growth rate (CAGR), from 11.1× to -5.2×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.